Omega Healthcare Investors (NYSE:OHI) Price Target Increased to $33.00 by Analysts at Truist Financial

Omega Healthcare Investors (NYSE:OHI) had its price objective raised by Truist Financial from $32.00 to $33.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock.

Several other equities analysts also recently commented on the stock. Citigroup upgraded shares of Omega Healthcare Investors from a neutral rating to a buy rating and upped their price objective for the company from $32.00 to $35.00 in a report on Friday, March 22nd. JMP Securities reiterated a market perform rating on shares of Omega Healthcare Investors in a report on Monday, May 6th. Finally, Wells Fargo & Company upgraded shares of Omega Healthcare Investors to a strong-buy rating in a report on Friday, June 14th. Eight analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus price target of $33.71.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $33.44 on Wednesday. Omega Healthcare Investors has a one year low of $27.53 and a one year high of $34.77. The company has a market cap of $8.26 billion, a P/E ratio of 30.12, a P/E/G ratio of 1.22 and a beta of 0.96. The firm’s fifty day moving average price is $31.47 and its two-hundred day moving average price is $30.90. The company has a debt-to-equity ratio of 1.36, a current ratio of 6.68 and a quick ratio of 6.68.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th were given a dividend of $0.67 per share. The ex-dividend date was Monday, April 29th. This represents a $2.68 annualized dividend and a yield of 8.02%. Omega Healthcare Investors’s dividend payout ratio is 241.44%.

Institutional Investors Weigh In On Omega Healthcare Investors

Several institutional investors and hedge funds have recently bought and sold shares of OHI. Left Brain Wealth Management LLC increased its stake in Omega Healthcare Investors by 2.0% in the 4th quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust’s stock worth $532,000 after purchasing an additional 335 shares during the period. Tidal Investments LLC increased its stake in Omega Healthcare Investors by 2.5% in the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock worth $454,000 after purchasing an additional 348 shares during the period. Royal Fund Management LLC increased its stake in Omega Healthcare Investors by 1.0% in the 4th quarter. Royal Fund Management LLC now owns 35,656 shares of the real estate investment trust’s stock worth $1,093,000 after purchasing an additional 369 shares during the period. Quadrant Capital Group LLC increased its stake in Omega Healthcare Investors by 11.5% in the 4th quarter. Quadrant Capital Group LLC now owns 3,834 shares of the real estate investment trust’s stock worth $118,000 after purchasing an additional 394 shares during the period. Finally, Future Financial Wealth Managment LLC increased its stake in Omega Healthcare Investors by 5.0% in the 1st quarter. Future Financial Wealth Managment LLC now owns 8,403 shares of the real estate investment trust’s stock worth $266,000 after purchasing an additional 400 shares during the period. Institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.